• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For February 28, 2023

    2/28/23 4:34:56 AM ET
    $NFE
    $NNI
    $NRDY
    $NSTG
    Oil/Gas Transmission
    Utilities
    Finance: Consumer Services
    Finance
    Get the next $NFE alert in real time by email

    Companies Reporting Before The Bell

    • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

    • MINISO Group Holding (NYSE:MNSO) is expected to report quarterly earnings at $0.13 per share on revenue of $364.68 million.

    • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is likely to report quarterly loss at $0.22 per share on revenue of $45.83 million.

    • TG Therapeutics (NASDAQ:TGTX) is expected to report quarterly loss at $0.26 per share on revenue of $1.83 million.

    • Compass Pathways (NASDAQ:CMPS) is likely to report earnings for its fourth quarter.

    • Black Knight (NYSE:BKI) is projected to report quarterly earnings at $0.54 per share on revenue of $387.84 million.

    • BlackRock TCP Cap (NASDAQ:TCPC) is projected to report quarterly earnings at $0.39 per share on revenue of $46.68 million.

    • Sculptor Cap (NYSE:SCU) is likely to report quarterly earnings at $0.17 per share on revenue of $101.45 million.

    • Pacira BioSciences (NASDAQ:PCRX) is expected to report quarterly earnings at $0.83 per share on revenue of $173.50 million.

    • Perficient (NASDAQ:PRFT) is projected to report quarterly earnings at $1.13 per share on revenue of $236.02 million.

    • Cracker Barrel Old (NASDAQ:CBRL) is estimated to report quarterly earnings at $1.36 per share on revenue of $917.47 million.

    • Heska (NASDAQ:HSKA) is projected to report quarterly loss at $0.04 per share on revenue of $64.66 million.

    • Delek Logistics Partners (NYSE:DKL) is likely to report quarterly earnings at $1.09 per share on revenue of $294.15 million.

    • Delek US Hldgs (NYSE:DK) is projected to report quarterly earnings at $0.87 per share on revenue of $3.34 billion.

    • Spirit Realty Cap (NYSE:SRC) is projected to report earnings for its fourth quarter.

    • Cronos Group (NASDAQ:CRON) is projected to report quarterly loss at $0.07 per share on revenue of $32.02 million.

    • Target Hospitality (NASDAQ:TH) is likely to report quarterly loss at $0.10 per share on revenue of $28.90 million.

    • Beauty Health (NASDAQ:SKIN) is projected to report quarterly earnings at $0.04 per share on revenue of $94.61 million.

    • Jones Lang LaSalle (NYSE:JLL) is estimated to report quarterly earnings at $4.44 per share on revenue of $2.26 billion.

    • Altimmune (NASDAQ:ALT) is expected to report quarterly loss at $0.50 per share on revenue of $30 thousand.

    • JM Smucker (NYSE:SJM) is estimated to report quarterly earnings at $2.12 per share on revenue of $2.22 billion.

    • Bentley Systems (NASDAQ:BSY) is estimated to report quarterly earnings at $0.19 per share on revenue of $279.98 million.

    • Norwegian Cruise Line (NYSE:NCLH) is likely to report quarterly loss at $0.85 per share on revenue of $1.50 billion.

    • Dorman Products (NASDAQ:DORM) is expected to report quarterly earnings at $1.08 per share on revenue of $449.42 million.

    • Builders FirstSource (NYSE:BLDR) is estimated to report quarterly earnings at $2.36 per share on revenue of $4.26 billion.

    • Nexstar Media Group (NASDAQ:NXST) is likely to report quarterly earnings at $8.26 per share on revenue of $1.50 billion.

    • Clear Channel Outdoor (NYSE:CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $705.50 million.

    • AutoZone (NYSE:AZO) is expected to report quarterly earnings at $21.91 per share on revenue of $3.56 billion.

    • Olaplex Hldgs (NASDAQ:OLPX) is estimated to report quarterly earnings at $0.06 per share on revenue of $138.98 million.

    • Warby Parker (NYSE:WRBY) is estimated to report quarterly earnings at $0.00 per share on revenue of $142.51 million.

    • Intl Game Tech (NYSE:IGT) is likely to report quarterly earnings at $0.29 per share on revenue of $1.03 billion.

    • Playtika Holding (NASDAQ:PLTK) is estimated to report quarterly earnings at $0.17 per share on revenue of $627.65 million.

    • Easterly Government Props (NYSE:DEA) is estimated to report earnings for its fourth quarter.

    • Privia Health Group (NASDAQ:PRVA) is expected to report quarterly loss at $0.03 per share on revenue of $587.13 million.

    • Civeo (NYSE:CVEO) is projected to report quarterly loss at $0.61 per share on revenue of $145.96 million.

    • Advance Auto Parts (NYSE:AAP) is expected to report quarterly earnings at $2.39 per share on revenue of $2.42 billion.

    • Target (NYSE:TGT) is projected to report quarterly earnings at $1.40 per share on revenue of $30.67 billion.

    • Golar LNG (NASDAQ:GLNG) is estimated to report quarterly earnings at $0.53 per share on revenue of $79.05 million.

    • Bank of Nova Scotia (NYSE:BNS) is likely to report quarterly earnings at $2.03 per share on revenue of $8.27 billion.

    • New Fortress Energy (NASDAQ:NFE) is expected to report quarterly earnings at $0.53 per share on revenue of $734.38 million.

    • Thoughtworks Holding (NASDAQ:TWKS) is estimated to report quarterly earnings at $0.09 per share on revenue of $306.40 million.

    • Aurinia Pharmaceuticals (NASDAQ:AUPH) is likely to report quarterly loss at $0.27 per share on revenue of $27.78 million.

    • Dentsply Sirona (NASDAQ:XRAY) is projected to report quarterly earnings at $0.32 per share on revenue of $941.37 million.

    • First Advantage (NASDAQ:FA) is likely to report quarterly earnings at $0.29 per share on revenue of $217.44 million.

    • Interface (NASDAQ:TILE) is likely to report quarterly earnings at $0.27 per share on revenue of $338.00 million.

    • Bank of Montreal (NYSE:BMO) is estimated to report quarterly earnings at $3.18 per share on revenue of $7.29 billion.

    • Frontline (NYSE:FRO) is expected to report quarterly earnings at $1.06 per share on revenue of $365.02 million.

    • Perimeter Solutions (NYSE:PRM) is projected to report quarterly loss at $0.13 per share on revenue of $40.77 million.

    • ADC Therapeutics (NYSE:ADCT) is estimated to report quarterly loss at $0.29 per share on revenue of $65.49 million.

    • Daqo New Energy (NYSE:DQ) is estimated to report quarterly earnings at $7.37 per share on revenue of $987.83 million.

    • Mersana Therapeutics (NASDAQ:MRSN) is projected to report quarterly loss at $0.50 per share on revenue of $15.28 million.

    • Gogo (NASDAQ:GOGO) is estimated to report quarterly earnings at $0.16 per share on revenue of $107.10 million.

    • ADT (NYSE:ADT) is projected to report quarterly earnings at $0.18 per share on revenue of $1.62 billion.

    • Nuwellis (NASDAQ:NUWE) is likely to report quarterly loss at $24.65 per share on revenue of $2.20 million.

    • Veritiv (NYSE:VRTV) is expected to report quarterly earnings at $5.44 per share on revenue of $1.75 billion.

    • eHealth (NASDAQ:EHTH) is estimated to report quarterly earnings at $0.56 per share on revenue of $185.95 million.

    • Clover Health Investments (NASDAQ:CLOV) is likely to report quarterly loss at $0.25 per share on revenue of $785.38 million.

    • Consolidated Comms Hldgs (NASDAQ:CNSL) is likely to report quarterly loss at $0.17 per share on revenue of $287.23 million.

    • Ituran Location & Control (NASDAQ:ITRN) is likely to report quarterly earnings at $0.52 per share on revenue of $74.60 million.

    • Chico's FAS (NYSE:CHS) is estimated to report earnings for its fourth quarter.

    • Sempra Energy (NYSE:SRE) is estimated to report quarterly earnings at $2.04 per share on revenue of $3.79 billion.

    • Shift4 Payments (NYSE:FOUR) is projected to report quarterly earnings at $0.38 per share on revenue of $545.62 million.

    • Hayward Holdings (NYSE:HAYW) is likely to report quarterly earnings at $0.12 per share on revenue of $260.17 million.

    • International Seaways (NYSE:INSW) is expected to report quarterly earnings at $3.64 per share on revenue of $310.01 million.

    • FTC Solar (NASDAQ:FTCI) is projected to report quarterly loss at $0.11 per share on revenue of $30.38 million.

    • Ocwen Financial (NYSE:OCN) is projected to report quarterly loss at $0.44 per share on revenue of $254.49 million.

    • Fusion Fuel Green (NASDAQ:HTOO) is likely to report earnings for its fourth quarter.

    • Owens & Minor (NYSE:OMI) is estimated to report earnings for its fourth quarter.

    • Ocugen (NASDAQ:OCGN) is estimated to report quarterly loss at $0.10 per share on revenue of $2.60 million.

    • Sotera Health (NASDAQ:SHC) is projected to report quarterly earnings at $0.22 per share on revenue of $247.55 million.

    • Kontoor Brands (NYSE:KTB) is projected to report quarterly earnings at $0.67 per share on revenue of $668.80 million.

    • RadNet (NASDAQ:RDNT) is expected to report quarterly earnings at $0.15 per share on revenue of $347.27 million.

    • Vertex Energy (NASDAQ:VTNR) is expected to report quarterly earnings at $0.40 per share on revenue of $912.58 million.

    • Theratechnologies (NASDAQ:THTX) is likely to report quarterly loss at $0.08 per share on revenue of $21.42 million.

    • American Woodmark (NASDAQ:AMWD) is estimated to report quarterly earnings at $1.78 per share on revenue of $511.95 million.

    • Mondee Hldgs (NASDAQ:MOND) is projected to report quarterly loss at $0.07 per share on revenue of $38.12 million.

    • Carrols Restaurant Group (NASDAQ:TAST) is expected to report quarterly loss at $0.21 per share on revenue of $438.69 million.

    • XPEL (NASDAQ:XPEL) is estimated to report quarterly earnings at $0.44 per share on revenue of $84.14 million.

    • Zevia (NYSE:ZVIA) is expected to report quarterly loss at $0.15 per share on revenue of $31.01 million.

    • Codere Online Luxembourg (NASDAQ:CDRO) is projected to report earnings for its fourth quarter.

    • Butterfly Network (NYSE:BFLY) is estimated to report quarterly loss at $0.22 per share on revenue of $19.93 million.

    • Allot (NASDAQ:ALLT) is estimated to report quarterly loss at $0.16 per share on revenue of $33.54 million.

    • Ecovyst (NYSE:ECVT) is expected to report quarterly earnings at $0.23 per share on revenue of $189.45 million.

    • Lindblad Expeditions (NASDAQ:LIND) is estimated to report quarterly loss at $0.46 per share on revenue of $94.26 million.

    • Mallinckrodt (AMEX:MNK) is likely to report earnings for its fourth quarter.

    • Sibanye Stillwater (NYSE:SBSW) is projected to report earnings for its Fiscal Year 2022.

    • Itau Corpbanca (NYSE:ITCB) is expected to report earnings for its fourth quarter.

    • SeaWorld Entertainment (NYSE:SEAS) is estimated to report quarterly earnings at $0.73 per share on revenue of $382.08 million.

    • HUTCHMED (China) (NASDAQ:HCM) is expected to report earnings for its Fiscal Year 2022.

    • MultiPlan (NYSE:MPLN) is projected to report quarterly loss at $0.05 per share on revenue of $240.04 million.

    • APi Gr (NYSE:APG) is estimated to report quarterly earnings at $0.34 per share on revenue of $1.63 billion.

    Companies Reporting After The Bell

    • Buenaventura Mining Co (NYSE:BVN) is likely to report earnings for its fourth quarter.

    • Enviva (NYSE:EVA) is expected to report quarterly earnings at $0.57 per share on revenue of $422.30 million.

    • MBIA (NYSE:MBI) is estimated to report quarterly loss at $0.31 per share on revenue of $6.00 million.

    • Jackson Finl (NYSE:JXN) is expected to report quarterly earnings at $5.21 per share on revenue of $1.57 billion.

    • Ryan Specialty Holdings (NYSE:RYAN) is expected to report quarterly earnings at $0.26 per share on revenue of $427.63 million.

    • Urban Outfitters (NASDAQ:URBN) is estimated to report quarterly earnings at $0.38 per share on revenue of $1.37 billion.

    • Regenxbio (NASDAQ:RGNX) is projected to report quarterly loss at $1.23 per share on revenue of $37.45 million.

    • Smart Sand (NASDAQ:SND) is likely to report quarterly earnings at $0.00 per share on revenue of $65.70 million.

    • Novavax (NASDAQ:NVAX) is expected to report quarterly loss at $0.92 per share on revenue of $383.14 million.

    • Vroom (NASDAQ:VRM) is estimated to report quarterly loss at $0.69 per share on revenue of $268.22 million.

    • Rocket Companies (NYSE:RKT) is expected to report quarterly loss at $0.11 per share on revenue of $682.73 million.

    • Virgin Galactic Hldgs (NYSE:SPCE) is expected to report quarterly loss at $0.51 per share on revenue of $370 thousand.

    • Quotient Technology (NYSE:QUOT) is projected to report earnings for its fourth quarter.

    • The RealReal (NASDAQ:REAL) is expected to report quarterly loss at $0.35 per share on revenue of $157.68 million.

    • Ambarella (NASDAQ:AMBA) is expected to report quarterly earnings at $0.15 per share on revenue of $83.30 million.

    • Alexandria Real Estate (NYSE:ARE) is likely to report quarterly earnings at $0.20 per share on revenue of $1.16 billion.

    • PROCEPT BioRobotics (NASDAQ:PRCT) is likely to report quarterly loss at $0.54 per share on revenue of $23.01 million.

    • Blink Charging (NASDAQ:BLNK) is likely to report quarterly loss at $0.48 per share on revenue of $19.11 million.

    • Cutera (NASDAQ:CUTR) is likely to report quarterly loss at $0.24 per share on revenue of $68.24 million.

    • Ecopetrol (NYSE:EC) is expected to report quarterly earnings at $1.13 per share on revenue of $9.68 billion.

    • Myriad Genetics (NASDAQ:MYGN) is estimated to report quarterly loss at $0.16 per share on revenue of $169.46 million.

    • Big 5 Sporting Goods (NASDAQ:BGFV) is estimated to report quarterly earnings at $0.07 per share on revenue of $238.29 million.

    • eXp World Holdings (NASDAQ:EXPI) is projected to report quarterly loss at $0.02 per share on revenue of $1.06 billion.

    • Monster Beverage (NASDAQ:MNST) is likely to report quarterly earnings at $0.63 per share on revenue of $1.60 billion.

    • Natera (NASDAQ:NTRA) is expected to report quarterly loss at $1.42 per share on revenue of $215.55 million.

    • Service Properties Trust (NASDAQ:SVC) is projected to report earnings for its fourth quarter.

    • Eos Energy Enterprises (NASDAQ:EOSE) is likely to report quarterly loss at $0.72 per share on revenue of $2.99 million.

    • Omnicell (NASDAQ:OMCL) is likely to report quarterly earnings at $0.09 per share on revenue of $287.43 million.

    • Assured Guaranty (NYSE:AGO) is estimated to report quarterly earnings at $0.89 per share on revenue of $190.21 million.

    • Ambac Financial Group (NYSE:AMBC) is projected to report quarterly earnings at $0.88 per share on revenue of $130.40 million.

    • Ross Stores (NASDAQ:ROST) is projected to report quarterly earnings at $1.24 per share on revenue of $5.17 billion.

    • Cosan (NYSE:CSAN) is expected to report quarterly loss at $0.02 per share on revenue of $4.12 billion.

    • PetIQ (NASDAQ:PETQ) is estimated to report quarterly loss at $0.09 per share on revenue of $192.47 million.

    • CarGurus (NASDAQ:CARG) is projected to report quarterly earnings at $0.10 per share on revenue of $281.41 million.

    • Skyward Specialty (NASDAQ:SKWD) is projected to report quarterly earnings at $0.26 per share on revenue of $173.54 million.

    • Arcutis Biotherapeutics (NASDAQ:ARQT) is projected to report quarterly loss at $1.42 per share on revenue of $2.20 million.

    • Compass (NYSE:COMP) is estimated to report quarterly loss at $0.33 per share on revenue of $1.19 billion.

    • Axon Enterprise (NASDAQ:AXON) is estimated to report quarterly earnings at $0.51 per share on revenue of $305.87 million.

    • Rocket Lab USA (NASDAQ:RKLB) is expected to report quarterly loss at $0.07 per share on revenue of $49.24 million.

    • Alphatec Holdings (NASDAQ:ATEC) is expected to report quarterly loss at $0.28 per share on revenue of $100.92 million.

    • Rivian Automotive (NASDAQ:RIVN) is estimated to report quarterly loss at $1.94 per share on revenue of $747.39 million.

    • Accel Entertainment (NYSE:ACEL) is estimated to report quarterly earnings at $0.22 per share on revenue of $275.42 million.

    • Solid Power (NASDAQ:SLDP) is projected to report quarterly loss at $0.10 per share on revenue of $950 thousand.

    • Amphastar Pharmaceuticals (NASDAQ:AMPH) is expected to report quarterly earnings at $0.41 per share on revenue of $126.98 million.

    • Atea Pharmaceuticals (NASDAQ:AVIR) is estimated to report earnings for its fourth quarter.

    • Syndax Pharmaceuticals (NASDAQ:SNDX) is likely to report quarterly loss at $0.65 per share on revenue of $370 thousand.

    • Southwest Gas Hldgs (NYSE:SWX) is expected to report quarterly earnings at $1.58 per share on revenue of $1.20 billion.

    • Fabrinet (NYSE:FN) is expected to report quarterly earnings at $0.64 per share on revenue of $194.00 million.

    • Marchex (NASDAQ:MCHX) is projected to report quarterly loss at $0.02 per share on revenue of $12.90 million.

    • MiMedx Group (NASDAQ:MDXG) is estimated to report quarterly loss at $0.04 per share on revenue of $74.53 million.

    • Arteris (NASDAQ:AIP) is likely to report quarterly loss at $0.20 per share on revenue of $11.32 million.

    • Rogers (NYSE:ROG) is estimated to report quarterly earnings at $0.86 per share on revenue of $235.40 million.

    • Revance Therapeutics (NASDAQ:RVNC) is projected to report quarterly loss at $0.95 per share on revenue of $46.55 million.

    • Microvision (NASDAQ:MVIS) is estimated to report earnings for its fourth quarter.

    • Iovance Biotherapeutics (NASDAQ:IOVA) is estimated to report earnings for its fourth quarter.

    • Arcus Biosciences (NYSE:RCUS) is estimated to report quarterly loss at $1.07 per share on revenue of $23.31 million.

    • Sarepta Therapeutics (NASDAQ:SRPT) is estimated to report quarterly loss at $1.35 per share on revenue of $248.34 million.

    • Allogene Therapeutics (NASDAQ:ALLO) is projected to report quarterly loss at $0.70 per share on revenue of $60 thousand.

    • Marathon Digital Holdings (NASDAQ:MARA) is estimated to report quarterly loss at $0.16 per share on revenue of $34.95 million.

    • comScore (NASDAQ:SCOR) is expected to report quarterly loss at $0.07 per share on revenue of $95.53 million.

    • Talos Energy (NYSE:TALO) is estimated to report quarterly earnings at $0.73 per share on revenue of $345.44 million.

    • Horizon Tech Finance (NASDAQ:HRZN) is projected to report quarterly earnings at $0.39 per share on revenue of $23.06 million.

    • Gulfport Energy (NYSE:GPOR) is projected to report quarterly earnings at $2.30 per share on revenue of $320.67 million.

    • First Solar (NASDAQ:FSLR) is projected to report quarterly loss at $0.15 per share on revenue of $989.28 million.

    • GoodRx Holdings (NASDAQ:GDRX) is estimated to report quarterly earnings at $0.05 per share on revenue of $178.60 million.

    • Red Robin Gourmet Burgers (NASDAQ:RRGB) is expected to report quarterly loss at $0.62 per share on revenue of $289.01 million.

    • FIGS (NYSE:FIGS) is expected to report quarterly earnings at $0.01 per share on revenue of $135.43 million.

    • Health Catalyst (NASDAQ:HCAT) is estimated to report quarterly loss at $0.11 per share on revenue of $68.26 million.

    • B&G Foods (NYSE:BGS) is likely to report quarterly earnings at $0.22 per share on revenue of $583.90 million.

    • Grocery Outlet Holding (NASDAQ:GO) is projected to report quarterly earnings at $0.23 per share on revenue of $906.51 million.

    • Inter Parfums (NASDAQ:IPAR) is projected to report quarterly earnings at $0.29 per share on revenue of $294.02 million.

    • Clean Energy Fuels (NASDAQ:CLNE) is projected to report quarterly earnings at $0.01 per share on revenue of $123.41 million.

    • Jamf Holding (NASDAQ:JAMF) is likely to report quarterly earnings at $0.04 per share on revenue of $128.90 million.

    • ON24 (NYSE:ONTF) is likely to report quarterly loss at $0.09 per share on revenue of $46.15 million.

    • Payoneer Global (NASDAQ:PAYO) is estimated to report quarterly loss at $0.05 per share on revenue of $171.53 million.

    • Alexander & Baldwin (NYSE:ALEX) is likely to report quarterly earnings at $0.20 per share on revenue of $95.40 million.

    • SmileDirectClub (NASDAQ:SDC) is estimated to report quarterly loss at $0.21 per share on revenue of $90.62 million.

    • PubMatic (NASDAQ:PUBM) is expected to report quarterly earnings at $0.26 per share on revenue of $76.71 million.

    • Flywire (NASDAQ:FLYW) is likely to report quarterly loss at $0.10 per share on revenue of $67.79 million.

    • Whitestone REIT (NYSE:WSR) is estimated to report quarterly earnings at $0.06 per share on revenue of $35.76 million.

    • ICF International (NASDAQ:ICFI) is likely to report quarterly earnings at $1.52 per share on revenue of $472.27 million.

    • Mirati Therapeutics (NASDAQ:MRTX) is expected to report quarterly loss at $3.55 per share on revenue of $2.27 million.

    • NanoString Technologies (NASDAQ:NSTG) is likely to report quarterly loss at $0.58 per share on revenue of $33.71 million.

    • Nerdy (NYSE:NRDY) is likely to report quarterly loss at $0.16 per share on revenue of $39.93 million.

    • 3D Sys (NYSE:DDD) is expected to report quarterly loss at $0.08 per share on revenue of $133.94 million.

    • Duolingo (NASDAQ:DUOL) is expected to report quarterly loss at $0.53 per share on revenue of $99.91 million.

    • Nextdoor Holdings (NYSE:KIND) is expected to report quarterly loss at $0.09 per share on revenue of $50.75 million.

    • AMC Entertainment (NYSE:AMC) is expected to report quarterly loss at $0.19 per share on revenue of $1.01 billion.

    • Coupang (NYSE:CPNG) is estimated to report quarterly earnings at $0.05 per share on revenue of $5.40 billion.

    • Mayville Engineering (NYSE:MEC) is likely to report quarterly earnings at $0.13 per share on revenue of $123.72 million.

    • OrthoPediatrics (NASDAQ:KIDS) is likely to report quarterly loss at $0.25 per share on revenue of $32.62 million.

    • Global Medical REIT (NYSE:GMRE) is likely to report quarterly earnings at $0.03 per share on revenue of $35.95 million.

    • Fate Therapeutics (NASDAQ:FATE) is projected to report quarterly loss at $0.86 per share on revenue of $16.72 million.

    • Supernus Pharmaceuticals (NASDAQ:SUPN) is projected to report quarterly earnings at $0.68 per share on revenue of $180.37 million.

    • VIZIO Holding (NYSE:VZIO) is likely to report quarterly earnings at $0.02 per share on revenue of $510.69 million.

    • Shoals Technologies Gr (NASDAQ:SHLS) is projected to report quarterly earnings at $0.08 per share on revenue of $85.96 million.

    • Nelnet (NYSE:NNI) is projected to report quarterly earnings at $1.57 per share on revenue of $337.04 million.

    • Alignment Healthcare (NASDAQ:ALHC) is estimated to report quarterly loss at $0.30 per share on revenue of $341.11 million.

    • Endeavor Gr Hldgs (NYSE:EDR) is likely to report quarterly earnings at $0.19 per share on revenue of $1.27 billion.

    • UMH Properties (NYSE:UMH) is expected to report quarterly loss at $0.01 per share on revenue of $51.68 million.

    • Marqeta (NASDAQ:MQ) is projected to report quarterly loss at $0.09 per share on revenue of $201.93 million.

    • Franchise Group (NASDAQ:FRG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.03 billion.

    • Montrose Environmental Gr (NYSE:MEG) is estimated to report quarterly loss at $0.26 per share on revenue of $141.24 million.

    • Cerus (NASDAQ:CERS) is expected to report quarterly loss at $0.05 per share on revenue of $45.96 million.

    • Hyliion Holdings (NYSE:HYLN) is projected to report quarterly loss at $0.20 per share on revenue of $790 thousand.

    • Corcept Therapeutics (NASDAQ:CORT) is estimated to report quarterly earnings at $0.22 per share on revenue of $105.08 million.

    • Fulgent Genetics (NASDAQ:FLGT) is expected to report quarterly loss at $0.56 per share on revenue of $59.57 million.

    • Masimo (NASDAQ:MASI) is expected to report quarterly earnings at $1.17 per share on revenue of $602.49 million.

    • Huron Consulting Gr (NASDAQ:HURN) is estimated to report quarterly earnings at $0.99 per share on revenue of $282.35 million.

    • Invitae (NYSE:NVTA) is estimated to report quarterly loss at $0.53 per share on revenue of $121.28 million.

    • Luxfer Holdings (NYSE:LXFR) is estimated to report quarterly earnings at $0.31 per share on revenue of $101.25 million.

    • Schrodinger (NASDAQ:SDGR) is projected to report quarterly loss at $0.53 per share on revenue of $47.43 million.

    • Forge Global Holdings (NYSE:FRGE) is projected to report quarterly loss at $0.15 per share on revenue of $17.88 million.

    • Cytek Biosciences (NASDAQ:CTKB) is projected to report quarterly earnings at $0.05 per share on revenue of $50.22 million.

    • Eventbrite (NYSE:EB) is expected to report quarterly loss at $0.14 per share on revenue of $70.99 million.

    • Castle Biosciences (NASDAQ:CSTL) is projected to report quarterly loss at $0.84 per share on revenue of $37.16 million.

    • Silk Road Medical (NASDAQ:SILK) is likely to report quarterly loss at $0.38 per share on revenue of $37.35 million.

    • Bain Capital Specialty (NYSE:BCSF) is projected to report quarterly earnings at $0.41 per share on revenue of $58.36 million.

    • HP (NYSE:HPQ) is estimated to report earnings for its first quarter.

    • iHeartMedia (NASDAQ:IHRT) is expected to report quarterly earnings at $0.44 per share on revenue of $1.11 billion.

    • Verisk Analytics (NASDAQ:VRSK) is likely to report quarterly earnings at $1.18 per share on revenue of $616.33 million.

    • Agilent Technologies (NYSE:A) is expected to report quarterly earnings at $1.30 per share on revenue of $1.70 billion.

    • Doma Holdings (NYSE:DOMA) is estimated to report quarterly loss at $0.10 per share on revenue of $81.08 million.

    • BRP Group (NASDAQ:BRP) is projected to report quarterly earnings at $0.12 per share on revenue of $234.70 million.

    • SLR Investment (NASDAQ:SLRC) is estimated to report quarterly earnings at $0.40 per share on revenue of $53.25 million.

    • Radius Global Infr (NASDAQ:RADI) is projected to report quarterly loss at $0.34 per share on revenue of $34.72 million.

    • OneSpan (NASDAQ:OSPN) is projected to report quarterly loss at $0.07 per share on revenue of $53.19 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $NFE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NFE
    $NNI
    $NRDY
    $NSTG

    CompanyDatePrice TargetRatingAnalyst
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Hold
    Truist
    Monster Beverage Corporation
    $MNST
    2/27/2026$80.00 → $88.00Hold
    TD Cowen
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Monster Beverage Corporation
    $MNST
    2/27/2026$80.00 → $100.00Buy
    Jefferies
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Neutral
    BofA Securities
    Monster Beverage Corporation
    $MNST
    2/27/2026$88.00 → $94.00Buy
    Deutsche Bank
    Target Corporation
    $TGT
    2/27/2026$103.00Underperform
    BofA Securities
    GoodRx Holdings Inc.
    $GDRX
    2/27/2026Overweight → Neutral
    Analyst
    More analyst ratings

    $NFE
    $NNI
    $NRDY
    $NSTG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Duolingo downgraded by Truist with a new price target

    Truist downgraded Duolingo from Buy to Hold and set a new price target of $100.00

    2/27/26 12:55:49 PM ET
    $DUOL
    Computer Software: Prepackaged Software
    Technology

    TD Cowen reiterated coverage on Monster Beverage with a new price target

    TD Cowen reiterated coverage of Monster Beverage with a rating of Hold and set a new price target of $88.00 from $80.00 previously

    2/27/26 12:43:30 PM ET
    $MNST
    Beverages (Production/Distribution)
    Consumer Staples

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    $NFE
    $NNI
    $NRDY
    $NSTG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $NFE
    $NNI
    $NRDY
    $NSTG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, SALES Sponsel David was granted 318,884 shares, increasing direct ownership by 91% to 668,384 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    2/27/26 9:30:15 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    GENERAL COUNSEL & CORP. SEC. Marshall Tyson Eliot was granted 302,852 shares, increasing direct ownership by 88% to 648,294 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    2/27/26 9:30:17 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CHIEF FINANCIAL OFFICER Koning John Todd was granted 335,868 shares, increasing direct ownership by 81% to 749,420 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    2/27/26 9:30:11 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $NFE
    $NNI
    $NRDY
    $NSTG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mission Success: Rocket Lab Launches 2nd Hypersonic Test Mission in Three Months for Defense Innovation Unit

    LONG BEACH, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today successfully launched its latest hypersonic test mission on its HASTE rocket for the Department of War's Defense Innovation Unit (DIU) – supporting a critical national priority to advance hypersonic technology for the United States and its allies. "That's Not A Knife" lifted off on February 27 at 7:00 p.m. Eastern (February 28, 00:00 UTC) from Rocket Lab Launch Complex 2 within the Virginia Spaceport Authority's Mid-Atlantic Regional Spaceport on Wallops Island, Virginia – the second successful launch of a h

    2/27/26 7:40:52 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    ADT Announces Grants of Inducement Equity Awards

    BOCA RATON, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE:ADT) today announced that its board of directors has approved the grant of equity awards in connection with ADT's acquisition of Origin Wireless, Inc., a privately held company that specializes in AI-enabled WiFi sensing technology ("Origin"), in reliance on the employment inducement awards exemption under the NYSE's Listed Company Manual Rule 303A.08. The board approved the grant of equity awards representing 8,070,357 shares of ADT common stock in the form of restricted stock units to 46 Origin employees who became ADT employees upon the closing of the acquisition. The board approved these awards to aid in the retention

    2/27/26 4:15:00 PM ET
    $ADT
    Diversified Commercial Services
    Consumer Discretionary

    Arcutis Management to Present at TD Cowen's 46th Annual Health Care Conference

    WESTLAKE VILLAGE, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will present at the TD Cowen 46th Annual Health Care Conference, taking place March 2-4, 2026, in Boston. Details for the Company's participation are as follows:     Fireside Chat: Monday, March 2, 2026 at 1:50 p.m. ET The webcast for this conference may be accessed via the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About ArcutisAr

    2/27/26 4:00:00 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NFE
    $NNI
    $NRDY
    $NSTG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $NFE
    $NNI
    $NRDY
    $NSTG
    SEC Filings

    View All

    Chairman & CEO, Skyward Group Robinson Andrew S bought $1,033,370 worth of shares (22,100 units at $46.76), increasing direct ownership by 15% to 167,674 units (SEC Form 4)

    4 - Skyward Specialty Insurance Group, Inc. (0001519449) (Issuer)

    2/27/26 4:56:40 PM ET
    $SKWD
    Property-Casualty Insurers
    Finance

    Director Phanstiel S. Louise bought $494,722 worth of shares (104,507 units at $4.73), increasing direct ownership by 59% to 281,951 units (SEC Form 4)

    4 - MYRIAD GENETICS INC (0000899923) (Issuer)

    2/27/26 4:46:18 PM ET
    $MYGN
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Ryan Patrick G Jr bought $1,033,975 worth of shares (25,865 units at $39.98), increasing direct ownership by 0.14% to 256,559 units (SEC Form 4)

    4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

    2/24/26 5:15:41 PM ET
    $RYAN
    Specialty Insurers
    Finance

    SEC Form FWP filed by Bank Of Montreal

    FWP - BANK OF MONTREAL /CAN/ (0000927971) (Subject)

    2/27/26 5:14:44 PM ET
    $BMO
    Commercial Banks
    Finance

    SEC Form FWP filed by Bank Of Montreal

    FWP - BANK OF MONTREAL /CAN/ (0000927971) (Subject)

    2/27/26 5:14:44 PM ET
    $BMO
    Commercial Banks
    Finance

    SEC Form 8-K filed by Ambarella Inc.

    8-K - AMBARELLA INC (0001280263) (Filer)

    2/27/26 5:13:15 PM ET
    $AMBA
    Semiconductors
    Technology

    $NFE
    $NNI
    $NRDY
    $NSTG
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of David A. McDonald and Martin J. Emerson to its Board of Directors, effective February 24, 2026. The appointments strengthen the Company's board with complementary expertise in public company leadership, capital markets, and medical device commercialization. "These appointments reflect our continued focus on operational discipline and long-term value creation," said John Erb, President and CEO of Nuwellis. "Marty has led multiple medical device organizations through scali

    2/26/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    The J.M. Smucker Co. Appoints Two New Independent Directors

    NRG Energy CFO Bruce Chung and Experienced Consumer Industry Executive David Singer to Join Board of DirectorsBoard Appointments Follow Constructive Engagement with Elliott Investment ManagementORRVILLE, Ohio, Feb. 26, 2026 /PRNewswire/ -- The J.M. Smucker Co. today announced it has appointed Woo-Sung (Bruce) Chung and David Singer to its Board of Directors, effective April 15, 2026. With the addition of Chung and Singer, the Board will comprise 11 directors, 10 of whom are independent, and all of whom are focused on advancing the work underway to drive continued growth, enhanced profitability, and disciplined capital allocation for the Company.The appointments follow constructive engagement

    2/26/26 7:00:00 AM ET
    $SJM
    Packaged Foods
    Consumer Staples

    WorkWhile Names Simon Khalaf CEO as Company Enters Next Phase of Growth and Expands Into Worker Financial Services

    Co-Founder Jarah Euston transitions to President and COO; Platform surpasses 1.2 million workers SAN FRANCISCO, Feb. 25, 2026 /PRNewswire/ -- WorkWhile today announced a leadership transition as the company moves into its next phase of growth. Tech veteran and longtime board member Simon Khalaf has been named Chief Executive Officer. Co-Founder Jarah Euston will transition to President and Chief Operating Officer, where she will focus on scaling operations and accelerating expansion. The transition comes at a moment of strength for the company. WorkWhile now serves more than 1.2

    2/25/26 1:24:00 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    $NFE
    $NNI
    $NRDY
    $NSTG
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Rocket Companies Inc. on Jun 21

    Recently, there has been a series of insider purchases at Rocket Companies Inc. by Director Rizik Matthew. On 2024-06-21, Director Rizik Matthew made a purchase of $8,648 worth of shares, acquiring 622 units at a price of $13.90. This transaction increased his direct ownership by 0.09% to 706,108 units, as reported in SEC Form 4. This purchase indicates confidence from an insider in the company's prospects. Building up to this latest purchase, Rizik Matthew had also bought shares in the previous month. On 2024-05-31, he acquired $4,375 worth of shares (317 units at $13.80), increasing his direct ownership by 0.05% to 702,497 units. Following this, he made purchases on 2024-06-05, 2024-06-07

    6/22/24 7:57:56 PM ET
    $RKT
    Finance: Consumer Services
    Finance

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care

    Insider Trading: Significant Buy at Marchex Inc. on Jun 5

    On June 5, 2024, Miller Edwin A made a significant insider purchase at Marchex Inc., acquiring $272,000 worth of Class B Common Stock, amounting to 200,000 units at a price of $1.36 per unit. This transaction represented a substantial increase in direct ownership by 1,107%, bringing Edwin A's total holdings to 218,066 units as reported in the SEC Form 4. Examining this purchase in the context of previous insider activities reveals interesting patterns worth noting. Horowitz Russell C was granted 15,000 units of Class B Common Stock on October 2, 2023, resulting in a 2% increase in direct ownership to 991,918 units. Similarly, Wisehart Manuel W was granted 15,000 units on the same date, incr

    6/10/24 1:01:02 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $NFE
    $NNI
    $NRDY
    $NSTG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arcus Biosciences Inc.

    SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

    12/17/24 9:52:58 PM ET
    $RCUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Montrose Environmental Group Inc.

    SC 13G - Montrose Environmental Group, Inc. (0001643615) (Subject)

    12/17/24 4:20:32 PM ET
    $MEG
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $NFE
    $NNI
    $NRDY
    $NSTG
    Financials

    Live finance-specific insights

    View All

    BlackRock TCP Capital Corp. Announces 2025 Financial Results Including Fourth Quarter Net Investment Income of $0.26 Per Share; Declares a First Quarter Dividend of $0.17 Per Share

    BlackRock TCP Capital Corp. ("we," "us," "our," "TCPC" or the "Company"), a business development company (NASDAQ:TCPC), today announced its financial results for the fourth quarter and year ended December 31, 2025 and filed its Form 10-K with the U.S. Securities and Exchange Commission. FINANCIAL HIGHLIGHTS On a GAAP basis, net investment income for the quarter ended December 31, 2025 was $22.1 million, or $0.26 per share on a diluted basis, which exceeded the regular dividend of $0.25 per share paid on December 31, 2025. Excluding amortization of purchase discount recorded in connection with the Merger(1), adjusted net investment income(1) for the quarter ended December 31, 2025 was $

    2/27/26 8:05:00 AM ET
    $TCPC
    Finance/Investors Services
    Finance

    Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results

    Revenue of $83.3 million, growing 9% year-over-year GAAP gross profit of $32.6 million, or GAAP gross margin of 39.1%; Non-GAAP gross profit of $34.2 million, or Non-GAAP gross margin of 41.0% GAAP loss of $23.4 million, or ($0.76) per share; Non-GAAP income of $5.2 million, or $0.16 per share Ended the year with $705.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.3 million Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announce

    2/27/26 7:00:00 AM ET
    $FLGT
    Medical Specialities
    Health Care

    Gogo Announces Fourth Quarter and Full Year 2025 Results

    Total Q4 Revenue of $230.6 million, up 67% Year-over-Year; Service Revenue of $191.9 million, up 61% Year-over-Year  Full Year Results at High End of 2025 Guidance Range for Revenue, Adjusted EBITDA and Free Cash Flow Gogo Galileo and 5G Expected to Ramp in 2026 Company Provides 2026 Financial Guidance BROOMFIELD, Colo., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (NASDAQ:GOGO) ("Gogo" or the "Company"), a leading global provider of broadband connectivity services for the business and military/government aviation markets, today announced its financial results for the quarter ended December 31, 2025 and full year results for 2025. Fourth quarter and full year 2025 financial results fo

    2/27/26 7:00:00 AM ET
    $GOGO
    Telecommunications Equipment
    Consumer Discretionary